U.S. Consumer Durables Stock News

NasdaqGM:GPCR
NasdaqGM:GPCRPharmaceuticals

Structure Therapeutics’ Oral Obesity Drug Enters Phase 2 As Investor Focus Grows

Structure Therapeutics (NasdaqGM:GPCR) has advanced its lead obesity candidate GSBR-1290 into phase 2 clinical trials as an oral treatment. The move comes as the company draws increased attention for targeting the obesity market with a pill-based approach rather than injectables. Analyst optimism and early discussion about potential takeovers have put fresh focus on the stock. Structure Therapeutics, trading under NasdaqGM:GPCR, is drawing fresh interest after pushing GSBR-1290 into phase...
NYSE:MOH
NYSE:MOHHealthcare

Has The Market Gone Too Far In Marking Down Molina Healthcare (MOH) Shares?

If you are trying to figure out whether Molina Healthcare's share price reflects its true worth, the starting point is understanding how its current market price compares with a range of valuation checks. The stock last closed at US$176.84, with returns of a 4.4% decline over 7 days, 4.3% decline over 30 days, 0.9% decline year to date, 38.0% decline over 1 year, 41.3% decline over 3 years, and 18.2% decline over 5 years, which may have shifted how investors see its potential and its...
NYSE:TNC
NYSE:TNCMachinery

Tennant Sets 2026 Meeting Timeline As Undervalued Shares Show Steady Gains

Tennant Company set the date for its 2026 annual meeting of shareholders. The company also announced the deadline for shareholders to nominate director candidates for the 2026 board election. The update outlines the timetable that will guide board nominations and voting for NYSE:TNC. Tennant, trading on the NYSE under ticker NYSE:TNC, recently closed at $80.84. The stock is up 5.5% over the past week, 5.0% over the past month, and 9.3% year to date, while showing a 4.1% decline over the...
NasdaqGS:BNTX
NasdaqGS:BNTXBiotechs

BioNTech Hire Signals People Focus As Oncology Plans And Valuation Attract Attention

BioNTech (NasdaqGS:BNTX) has created a new Chief People Officer role. Kylie Jimenez has been appointed to the position, effective immediately. The move is tied to BioNTech’s goal of becoming a multi product oncology leader beyond its COVID 19 work. BioNTech, known widely for its COVID 19 vaccine partnership, is working to build a broader pipeline in oncology and other therapeutic areas. The new Chief People Officer role indicates that leadership views talent, organizational design, and...
NYSE:SHAK
NYSE:SHAKHospitality

Is Shake Shack (SHAK) Pricing Reflect Its Mixed Share Price Performance And Rich Valuation Metrics

If you have ever wondered whether Shake Shack's current share price reflects what you are actually getting as an investor, you are not alone. The stock recently closed at US$93.07, with returns of 5.7% over 7 days, 3.6% over 30 days, 11.5% year to date, 64.1% over 3 years, and a 19.2% decline over 1 year. Taken together, this gives a mixed picture of how the market has been reassessing it over different timeframes. Recent coverage has focused on Shake Shack as a branded fast casual player...
NYSE:NYT
NYSE:NYTMedia

New York Times (NYT) Margin Gains Reinforce Bullish Narratives Despite Premium P/E

The New York Times (NYT) closed out FY 2025 with Q4 revenue of US$802.3 million and basic EPS of US$0.80, compared with US$719.5 million of revenue and EPS of US$0.75 in the prior year’s Q4, pointing attention squarely to how efficiently the business is turning its top line into profit. Over the past six quarters, the company has seen quarterly revenue move from US$633.6 million in Q3 2024 to US$694.1 million in Q3 2025 and then to US$802.3 million in Q4 2025, while basic EPS ranged from...
NYSE:SRE
NYSE:SREIntegrated Utilities

Sempra Hydrogen Petition Seeks Faster Clarity On Future Gas Investments

Sempra subsidiaries Southern California Gas Co. and San Diego Gas & Electric have petitioned California regulators to drop a 5% hydrogen blending demonstration requirement. The filing argues that existing research and operational data are sufficient to assess low level hydrogen blending safety without new pilot projects. The request targets rules that would have required utilities to complete demonstration projects before regulators consider a systemwide hydrogen blending standard. Sempra,...
NYSE:WHR
NYSE:WHRConsumer Durables

Whirlpool’s TIME Honor Puts Brand Strength And US Manufacturing In Focus

Whirlpool (NYSE:WHR) has been named to TIME's inaugural "America’s Most Iconic Companies" list. The company is the only home appliance brand included, recognized for its cultural impact and commitment to U.S. manufacturing. This recognition highlights Whirlpool’s long history in American households and its continued domestic production footprint. For investors tracking Whirlpool at a share price of $85.09, this recognition arrives alongside mixed recent return data. The stock is up 10.6%...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

FDA NDA Move Puts Exelixis Colorectal Cancer Bet To The Test

FDA accepts Exelixis' New Drug Application for zanzalintinib plus atezolizumab in metastatic colorectal cancer. The application is based on pivotal trial data for patients with advanced disease. This step moves the investigational combination closer to potential commercial use in the United States. For investors watching NasdaqGS:EXEL, this FDA filing milestone is an important datapoint in the company’s oncology pipeline. Exelixis focuses on cancer therapies, and colorectal cancer is a...
NYSE:JHG
NYSE:JHGCapital Markets

Is Janus Henderson Group (JHG) Still Priced Attractively After Strong Multi‑Year Share Gains

If you are wondering whether Janus Henderson Group's current share price still makes sense, you are not alone. Many investors are asking if the stock offers solid value at today's level. The shares last closed at US$48.19, with returns of 0.5% over 7 days, 0.3% over 30 days, 0.9% year to date and 9.3% over 1 year, while 3-year and 5-year returns sit at very large levels close to a 2x gain. Recent attention on Janus Henderson Group has been shaped by coverage of its position in the global...
NYSE:ALL
NYSE:ALLInsurance

Allstate (ALL) Q4 Combined Ratio Of 80.1% Challenges Bearish Profitability Narratives

Allstate (ALL) just wrapped up FY 2025 with Q4 revenue of US$17.3b and basic EPS of US$14.55, capping off a trailing twelve month stretch where revenue reached US$67.7b and EPS came in at US$38.56 alongside year over year earnings growth of 123.4%. Over the past few quarters, the company has seen revenue move from US$16.5b and EPS of US$7.16 in Q4 2024 to US$16.6b and EPS of US$7.86 in Q2 2025, then to US$17.3b and EPS of US$14.55 in Q4 2025, setting up a story where stronger profitability...
NYSE:AMT
NYSE:AMTSpecialized REITs

Is American Tower (AMT) Offering Value After Recent Share Price Weakness?

If you are wondering whether American Tower's current share price reflects its underlying worth, you are not alone; many investors are asking the same question right now. The stock last closed at US$171.49, with returns of 5.4% decline over 7 days, 2.5% decline over 30 days, 1.9% decline year to date and 6.5% decline over the past year, alongside 11.8% decline over 3 years and 12.8% decline over 5 years. Recent news coverage around American Tower has focused on its role in providing wireless...
NasdaqGS:TPG
NasdaqGS:TPGCapital Markets

TPG Launches Third Wave Insurance As Earnings Mix Evolves

TPG (NasdaqGS:TPG) has launched Third Wave Insurance, a new retail insurance brokerage platform. The business is led by industry veteran Brian Bair and formed in partnership with Palmer & Cay. The move extends TPG beyond its traditional alternative asset management roots into insurance distribution. For investors watching TPG at a current share price of $53.54, this new insurance brokerage venture adds another business line alongside its existing funds platform. The stock has seen a 23.1%...
NYSE:LYB
NYSE:LYBChemicals

LyondellBasell Resets Portfolio And Capacity In Response To Tougher Cycle

LyondellBasell Industries (NYSE:LYB) is cutting global ethylene capacity and idling selected production through 2028 to address persistent weakness in chemicals markets. The company plans to divest four European assets as part of a broad portfolio overhaul aimed at focusing on higher value operations. These moves mark a clear inflection point for both LyondellBasell and the wider chemicals sector after a challenging period. LyondellBasell, trading at about $53.88, is taking these capacity...
NYSE:SF
NYSE:SFCapital Markets

Stronger Earnings, Dividend Hike, Buybacks Might Change The Case For Investing In Stifel Financial (SF)

Stifel Financial Corp. recently reported its fourth-quarter and full-year 2025 results, with quarterly revenue rising to US$1,752.86 million and net income reaching US$264.36 million, alongside an 11% increase in its common stock dividend and ongoing share repurchases under a long-running buyback program. An interesting angle for investors is how Stifel combined record adviser recruiting, stronger wealth and institutional activity, and disciplined expense control while still choosing to...
NYSE:CAH
NYSE:CAHHealthcare

Cardinal Health Guidance Hike Sparks Questions On Valuation And Growth Drivers

Cardinal Health reported a strong fiscal second quarter, with segment profit growth across all major businesses. The company raised its full year guidance for the second time within a month, reflecting confidence in current performance drivers. Recent acquisitions, including Solaris Health, and share repurchases were highlighted as key contributors to results. For investors watching NYSE:CAH, the recent operational update comes on top of a share price around $227.18 and a 1 year return of...
NYSE:FLS
NYSE:FLSMachinery

Flowserve Expands Nuclear Power Reach With Trillium Valves Acquisition

Flowserve (NYSE:FLS) announced an agreement to acquire Trillium Flow Technologies’ Valves Division. The deal expands Flowserve’s reach in nuclear and traditional power markets. The acquisition is expected to be accretive to earnings within the year. Flowserve (NYSE:FLS) is a global provider of flow control products and services, with a core focus on pumps, valves and related support for critical infrastructure. By adding Trillium’s Valves Division, the company is set to broaden its product...
NYSE:RNST
NYSE:RNSTBanks

Renasant (RNST) Valuation Check After Recent Share Momentum And Merger Growth Story

Renasant (RNST) has been drawing fresh attention after a strong recent share move, with the stock up around 14% over the past month and roughly 19% over the past 3 months. See our latest analysis for Renasant. The recent 1-week share price return of 8.4% and 30-day gain of 14.1% sit on top of a 16.6% year to date share price return and a 1-year total shareholder return of 7.3%. This suggests momentum has picked up recently from a more modest longer term profile. If Renasant’s move has you...
NYSE:KMT
NYSE:KMTMachinery

Kennametal Guidance Raised As Pricing Power And Project Wins Support Outlook

Kennametal (NYSE:KMT) reported quarterly results with revenue above internal expectations. The company raised its full-year revenue and adjusted EPS guidance following the quarter. Management cited pricing actions and new project wins in aerospace, energy, and mining as key supports. Restructuring efforts and cost improvements were noted as contributors to the updated outlook. Kennametal, a supplier of tooling and wear resistant solutions for industrial customers, is seeing traction across...
NYSE:CMS
NYSE:CMSIntegrated Utilities

CMS Energy Plans Long Term Renewables As Dividend Track Record Grows

CMS Energy (NYSE:CMS) received approval for a new twenty year renewable energy plan. The company secured a large load tariff to support a major customer investment program. CMS Energy also announced its twentieth consecutive annual dividend increase. CMS Energy, a regulated utility focused on electricity and natural gas service, is leaning further into long term renewable power planning at the same time that it puts a structured tariff around large customer demand. For you as an investor,...